KYTX · Kyverna Therapeutics, Inc.

$8.64 +0.03 (+0.35%) At close · Aug 27

Market Cap

$544.22M

61.84M

The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.

Type	Filing Date	Period
8-K	2026-08-11	—
10-Q	2026-08-11	2026-06-30
8-K	2026-07-27	2026-07-23
8-K	2026-07-09	2026-07-08
Investor Event Transcript	2026-06-03	2026-06-30
8-K	2026-06-02	2026-05-27
8-K	2026-05-18	2026-05-14
8-K	2026-05-12	—
10-Q	2026-05-12	2026-03-31
8-K	2026-05-04	—
Investor Event Transcript	2026-04-22	2026-06-30
8-K	2026-04-22	2026-04-21
8-K	2026-04-22	—
8-K	2026-04-20	—
DEF 14A	2026-04-13	2026-05-27
8-K	2026-03-26	—
10-K	2026-03-26	2025-12-31
8-K	2026-02-24	—
8-K	2026-02-03	2026-01-29
8-K	2026-01-12	2026-01-08
8-K	2025-12-18	2025-12-17
8-K	2025-12-15	—
8-K	2025-12-15	—
10-Q	2025-11-12	2025-09-30
8-K	2025-11-12	—
8-K	2025-11-03	2025-11-02
8-K	2025-10-29	—
8-K	2025-10-29	—
8-K	2025-09-25	2025-09-19
10-Q	2025-08-12	2025-06-30
8-K	2025-08-12	—
8-K	2025-06-30	—
8-K	2025-06-03	2025-05-29
8-K	2025-05-13	—
10-Q	2025-05-13	2025-03-31
DEF 14A	2025-04-14	2025-05-29
8-K	2025-03-27	—
10-K	2025-03-27	2024-12-31
8-K	2025-03-27	—
8-K	2025-01-21	—
8-K	2025-01-13	—
8-K	2024-11-26	—
10-Q	2024-11-13	2024-09-30
8-K	2024-11-13	2024-11-08
8-K	2024-10-21	2024-10-20
8-K	2024-09-16	2024-09-13
8-K	2024-08-12	—
10-Q	2024-08-12	2024-06-30
8-K	2024-07-15	—
8-K	2024-06-14	—

Showing 1–50 of 55 filings

Key facts CIK 1994702 CUSIP 501976104 13F (30d) 106 filings 105 filers Visit website Investor relations